197 related articles for article (PubMed ID: 17028239)
1. Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance.
Termont S; Vandenbroucke K; Iserentant D; Neirynck S; Steidler L; Remaut E; Rottiers P
Appl Environ Microbiol; 2006 Dec; 72(12):7694-700. PubMed ID: 17028239
[TBL] [Abstract][Full Text] [Related]
2. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10.
Huyghebaert N; Vermeire A; Neirynck S; Steidler L; Remaut E; Remon JP
Eur J Pharm Biopharm; 2005 Aug; 60(3):349-59. PubMed ID: 15927456
[TBL] [Abstract][Full Text] [Related]
3. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.
Steidler L; Neirynck S; Huyghebaert N; Snoeck V; Vermeire A; Goddeeris B; Cox E; Remon JP; Remaut E
Nat Biotechnol; 2003 Jul; 21(7):785-9. PubMed ID: 12808464
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
5. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice.
Vandenbroucke K; Hans W; Van Huysse J; Neirynck S; Demetter P; Remaut E; Rottiers P; Steidler L
Gastroenterology; 2004 Aug; 127(2):502-13. PubMed ID: 15300583
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease.
del Carmen S; de Moreno de LeBlanc A; Perdigon G; Bastos Pereira V; Miyoshi A; Azevedo V; LeBlanc JG
J Mol Microbiol Biotechnol; 2011; 21(3-4):138-46. PubMed ID: 22286041
[TBL] [Abstract][Full Text] [Related]
7. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
[TBL] [Abstract][Full Text] [Related]
8. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
[TBL] [Abstract][Full Text] [Related]
10. Intracellular Expression of Antifreeze Peptides in Food Grade Lactococcus lactis and Evaluation of Their Cryoprotective Activity.
Zhang L; Jin Q; Luo J; Wu J; Wang S; Wang Z; Gong S; Zhang W; Lan X
J Food Sci; 2018 May; 83(5):1311-1320. PubMed ID: 29660758
[TBL] [Abstract][Full Text] [Related]
11. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
12. Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice.
Waeytens A; Ferdinande L; Neirynck S; Rottiers P; De Vos M; Steidler L; Cuvelier CA
Inflamm Bowel Dis; 2008 Apr; 14(4):471-9. PubMed ID: 18092343
[TBL] [Abstract][Full Text] [Related]
13. Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis.
Rottiers P; De Smedt T; Steidler L
Int Rev Immunol; 2009; 28(6):465-86. PubMed ID: 19954359
[TBL] [Abstract][Full Text] [Related]
14. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
[TBL] [Abstract][Full Text] [Related]
15. Actobiotics as a novel method for cytokine delivery.
Steidler L; Rottiers P; Coulie B
Ann N Y Acad Sci; 2009 Dec; 1182():135-45. PubMed ID: 20074282
[TBL] [Abstract][Full Text] [Related]
16. Effects of temperature and trehalose on foam separation of nisin from the culture broth produced by Lactococcus lactis subspecies lactis W28.
Wang Y; Nan F; Zheng H; Wu Z
J Dairy Sci; 2012 Oct; 95(10):5588-96. PubMed ID: 22901486
[TBL] [Abstract][Full Text] [Related]
17. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
Bermúdez-Humarán LG; Motta JP; Aubry C; Kharrat P; Rous-Martin L; Sallenave JM; Deraison C; Vergnolle N; Langella P
Microb Cell Fact; 2015 Feb; 14():26. PubMed ID: 25889561
[TBL] [Abstract][Full Text] [Related]
18. Churning out safer microbes for drug delivery.
Syvanen M
Nat Biotechnol; 2003 Jul; 21(7):758-9. PubMed ID: 12833095
[No Abstract] [Full Text] [Related]
19. Trehalose-mediated protection of the plasma membrane H+-ATPase from Kluyveromyces lactis during freeze-drying and rehydration.
Sampedro JG; Guerra G; Pardo JP; Uribe S
Cryobiology; 1998 Sep; 37(2):131-8. PubMed ID: 9769163
[TBL] [Abstract][Full Text] [Related]
20. Variations of N-acetylation level of peptidoglycan do not influence persistence of Lactococcus lactis in the gastrointestinal tract.
Watterlot L; Meyrand M; Gaide N; Kharrat P; Blugeon S; Gratadoux JJ; Flores MJ; Langella P; Chapot-Chartier MP; Bermúdez-Humarán LG
Int J Food Microbiol; 2010 Nov; 144(1):29-34. PubMed ID: 20851488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
